A judicial panel has ruled that all suits filed against a pharmacy linked to a multi-state fungal meningitis outbreak will be heard in federal court in Massachusetts. The panel ruled yesterday that the more than 120 suits filed in the case against the New England Compounding Center will be assigned to one judge. Some plaintiffs had requested the cases be centralized in Minnesota. But the panel said the litigation was best centralized in Massachusetts because the primary witnesses and evidence will likely be located there. The fungal meningitis outbreak, discovered in Tennessee in September, has been blamed on a steroid produced by the NECC. It's sickened more than 650 and killed 46.